Profil
Fei Jiang currently holds the positions of Non-Executive Director at Tyligand Bioscience Ltd. starting in 2026, Non-Executive Director at Eastenova (Chengdu) Biotechnology Co., Ltd. starting in 2025, and Chief Investment Officer at China Medical System Holdings Ltd. starting in 2022.
Education history includes a doctorate degree from Syracuse University conferred in 2006 and an undergraduate degree from East China University of Science & Technology conferred in 1998.
Postes actifs de Fei Jiang
| Sociétés | Poste | Début |
|---|---|---|
| CHINA MEDICAL SYSTEM HOLDINGS LIMITED | Directeur en chef des Investissements | 01/01/2022 |
Tyligand Bioscience Ltd
Tyligand Bioscience Ltd BiotechnologyHealth Technology Engages in discovery and development of cancer therapeutics | Directeur/Membre du Conseil | 01/04/2024 |
Formation de Fei Jiang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Syracuse University
Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Medical System Holdings Ltd.
China Medical System Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes prescription drugs and pharmaceutical products | Health Technology |
East China University of Science & Technology
East China University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tyligand Bioscience Ltd
Tyligand Bioscience Ltd BiotechnologyHealth Technology Engages in discovery and development of cancer therapeutics | Health Technology |
















